Table 1 Key components of OBOT
From: Financial sustainability of payment models for office-based opioid treatment in outpatient clinics
Component | Details |
|---|---|
1. Clinician(s) who prescribe(s) buprenorphine | Physician or other prescriber authorized to prescribe buprenorphine—until April 2021, limited to those who completed DEA waiver training |
2. Nurses/other clinicians who support or lead care management | In most (but not all) models, the prescriber is supported by nurses and/or other clinicians who coordinate patient follow-up, buprenorphine prescription refills, drug testing, etc |
3. Technical assistance | May include both training sessions and provider-to-provider consultations |
4. Linkage to a ‘hub’ | Optional: some OBOT clinics are linked to a ‘hub’ (typically an Opioid Treatment Program) where patients typically receive induction and stabilization, before transferring to the clinic (‘spoke’) for maintenance |